Kanade Shinkai, MD

Dermatologist

Dr. Kanade Shinkai is an attending physician in the Dermatology Clinic. She has expertise in dermatology of hospitalized, systemically ill patients. She sees patients with all types of skin disease but specializes in complex medical dermatology with a focus on autoimmune and autoinflammatory disorders of skin. Shinkai performs research on immunologic and inflammatory cutaneous diseases.

Clinics

Dermatology Clinic
1701 Divisadero St., Third and Fourth Floors
San Francisco, CA 94115
Phone: (415) 353–7800
Fax: (415) 353–7870

Hours: Monday to Friday, 8 a.m. – 5 p.m.

PCOS Clinic
499 Illinois St.
San Francisco, CA 94158
Phone: (415) 885-3674
Fax: (415) 353-7744

Hours: Two Thursdays a month
8 a.m. – 5 p.m.

Board Certification

Dermatology, American Board of Dermatology

Academic Title

Professor

More about Kanade Shinkai

Education

UCSF School of Medicine 2004

Residencies

UCSF Medical Center, Dermatology 2008

Selected Research and Publications

  1. Micheletti RG, Chiesa-Fuxench Z, Noe MH, Stephen S, Aleshin M, Agarwal A, Boggs J, Cardones AR, Chen JK, Cotliar J, Davis MD, Dominguez A, Fox LP, Gordon S, Hamrick R, Ho B, Hughey LC, Jones LM, Kaffenberger BH, Kindley K, Kroshinsky D, Kwong BY, Miller DD, Mostaghimi A, Musiek A, Ortega-Loayza AG, Patel R, Posligua A, Rani M, Saluja S, Sharon VR, Shinkai K, John JS, Strickland N, Summers EM, Sun N, Wanat KA, Wetter DA, Worswick S, Yang C, Margolis DJ, Gelfand JM, Rosenbach M. Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis: a multicenter retrospective study of 377 adult patients from the United States. J Invest Dermatol. 2018 May 11.
  2. Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, Marzano AV, Wallach D, Kim K, Schadt C, Ormerod A, Fung MA, Steel A, Patel F, Qin R, Craig F, Williams HC, Powell F, Merleev A, Cheng MY. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts. JAMA Dermatol. 2018 Apr 01; 154(4):461-466.
  3. Noe MH, Mostaghemi A, Rosenbach M, Shinkai K, Micheletti RG. Selective use of cyclosporine for Stevens-Johnson syndrome / toxic epidermal necrolysis may exclude patients with poor prognostic factors. J Invest Dermatol. 2018 Mar 17.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.